IL6 and cancer: Chronic inflammation, sustained by elevated levels of IL-6 and other pro-inflammatory cytokines, perpetuates persistent activation of STAT3, establishing a self-reinforcing cycle that drives the progression of cancer cachexia (14, 15, 29, 30).